Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Chubb
UBS
McKesson
Teva
Express Scripts
Boehringer Ingelheim
McKinsey

Generated: June 19, 2018

DrugPatentWatch Database Preview

HYDRALAZINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydralazine Hydrochloride, and what generic alternatives are available?

Hydralazine Hydrochloride is a drug marketed by Abraxis Pharm, Akorn, Fresenius Kabi Usa, Luitpold, Mylan Institutional, Navinta Llc, Smith And Nephew, Solopak, Teva Parenteral, X-gen Pharms Inc, Actavis Elizabeth, Actavis Grp Ptc, Alkem Labs Ltd, Anda Repository, Ascot, Cadila Pharms Ltd, Chartwell Rx, Glenmark Pharms Ltd, Halsey, Heritage Pharms Inc, Hetero Labs Ltd Iii, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Quantum Pharmics, Sciegen Pharms Inc, Strides Pharma, Superpharm, Upsher-smith Labs, Usl Pharma, Vangard, Vitarine, Watson Labs, West Ward, Solvay, and Ivax Pharms. and is included in ninety-one NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE
Pharmacology for HYDRALAZINE HYDROCHLORIDE
Synonyms for HYDRALAZINE HYDROCHLORIDE
(1Z)-1-hydrazinylidene-2H-phthalazine hydrochloride
(Z)-1-Hydrazono-1,2-dihydrophthalazine hydrochloride
1-hydrazinophthalazine HCL
1-Hydrazinophthalazine hydrochloride
1-Hydrazinophthalazine monohydrochloride
1-hydrazinyl-Phthalazine hydrochloride
1-Hydrazinylphthalazine hydrochloride
1-Hydrazinylphthalazinehydrochloride
1(2H)-Phthalazinone hydrazone hydrochloride
1(2H)-Phthalazinone, hydrazone, hydrochloride
1(2H)-Phthalazinone, hydrazone, monohydrochloride
1(2H)-Phthalazinone, hydrochloride
1(2H)-Phthalazinone, monohydrochloride
1044569-46-1
304-20-1
81411-23-6
AB0062919
AB2000658
AC-18050
AC1L1SV4
AC1Q3COW
AC1Q3DGV
ACMC-209hfr
Aiselazine
AK-51529
AK499698
AKOS008968535
AKOS025116605
AKOS028109609
AN-1061
ANW-26869
AOB5342
Apresoline
Apresoline (TN)
Apresoline hydrochloride
ARONIS27196
BPI-103
C8H8N4.HCl
CAS-304-20-1
CCG-40185
CHEBI:31672
CHEMBL542541
CS-2578
CTK3E4473
CTK8B1415
D01302
Dralzine
DSSTox_CID_24645
DSSTox_GSID_44645
DSSTox_RID_80373
DTXSID1044645
EN300-03637
EU-0100593
FT-0669283
H 1753
HE042444
HE177861
HE177864
HMS1568B19
HMS1920D17
HY-B0464
Hydralazine (hydrochloride)
Hydralazine chloride
HYDRALAZINE HCL
Hydralazine hydrochloride (JP17/USP)
Hydralazine hydrochloride [JAN]
Hydralazine mono-Hydrochloride
Hydralazine monohydrochloride
Hydralazinhydrochlorid
Hydrallazine hydrochloride
Hyperazin
Hyperex
I14-85667
KS-00000XOB
KS-000048OG
KSC911I1L
Lopress
LP00593
LS-109173
MCULE-9301781478
MolPort-003-666-202
MolPort-003-941-613
mono-HYDRAZINOPHTHALAZINE HCl
NCGC00015501-02
NCGC00015501-09
NCGC00093972-01
NCGC00093972-02
NCGC00093972-03
NCGC00093972-04
NCGC00256719-01
NCGC00261278-01
NE41773
NSC-757058
NSC-89394
NSC757058
NSC89394
Pharmakon1600-01500334
phthalazin-1-ylhydrazine hydrochloride
Phthalazine, monohydrochloride
Phthalazinone hydrazone monohydrochloride
Phthalazinone, monohydrochloride
Prestwick_610
Q-201208
RTR-013075
s2562
SBB000358
SC-16076
SCHEMBL36271
Slow-Apresolin
SPECTRUM1500334
SR-01000075903
SR-01000075903-1
ST50825409
Tox21_110163
Tox21_110163_1
Tox21_302496
Tox21_500593
TR-013075
WLN: T66 CNNJ BMZ & GH
Z57980178
ZUXNZUWOTSUBMN-UHFFFAOYSA-N

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 086961-002 Approved Prior to Jan 1, 1982 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vangard HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 087712-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Halsey HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 089178-001 Jan 15, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chartwell Rx HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088848-001 Feb 26, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Johnson and Johnson
Chubb
Fuji
US Department of Justice
UBS
Julphar
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.